New Enterprise Associates 17, L.P. Insider Profile
4 Followers
New Enterprise Associates 17, L.P., Ten Percent Owner at Monte Rosa Therapeutics, holds 1.30M shares in Korro Bio (Ticker: KRRO), holds 6.04M shares in SpyGlass Pharma (Ticker: SGP), holds 0.00 shares in NeueHealth Inc (Ticker: NEUE). Most recently, New Enterprise Associates 17, L.P. Bought ― shares of Korro Bio on Mar 12, 2026 for an estimated value of $2.30M.
What was New Enterprise Associates 17, L.P.’s latest transaction?
New Enterprise Associates 17, L.P. latest transaction was an Informative Buy of $2.30M.
What was New Enterprise Associates 17, L.P.'s most profitable transaction?
New Enterprise Associates 17, L.P.’s most profitable transaction was an Informative Buy of NEUE stock on October 6, 2025. The return on the trade was 0.00%.
What is New Enterprise Associates 17, L.P.'s role in Monte Rosa Therapeutics?
New Enterprise Associates 17, L.P.'s role in Monte Rosa Therapeutics is Ten Percent Owner.
How can I follow the stock ratings of top corporate insiders?
Head over to our Expert Center to see a list of the Top 100 corporate insiders and follow the corporate insiders of your choice. Visit their profiles for more details about their stock transactions and see how they perform on a stock-by-stock basis.